Senior insider sale
CAAO and PAO at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$3.59M
110.40K shares
What this filing means
GILLIS JONATHAN plans to sell 110.40K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $3.59M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/15/2026ACC: 0001193125-26-305149
Officer· CAAO and PAO
Since Feb 2026
110.40K
Shares to sell
$3.59M
Approx. market value
36.98K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted stock unit settlement
N/A
7/15/2026
36.98KTotal acquired36.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/15/2026 | Restricted stock unit settlement N/A | 36.98K | — |
| Total | 36.98K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
17.93K
Market value
$544.3K
4/28/2026
—Completed
Units to sell
51.90K
Market value
$1.54M
4/27/2026
—Completed
Units to sell
3.59K
Market value
$95.5K
4/15/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
36.98K
Market value
$1.40M
7/15/2026
Total
Units
110.40K
Value
$3.59M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/28/2026 | 17.93K | $544.3K | — | Completed |
4/27/2026 | 51.90K | $1.54M | — | Completed |
4/15/2026 | 3.59K | $95.5K | — | Completed |
| Planned — Approximate Date | ||||
7/15/2026 | 36.98K | $1.40M | Nasdaq | Planned |
| Total | 110.40K | $3.59M | ||